Trial NCT00016276

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02380
Secondary IDs: CDR0000068617 CLB-49808 U10CA031946

Last trial update was posted on 2013-01-16

MeSH Interventions

Cyclophosphamide Dexrazoxane Doxorubicin Liposomal doxorubicin Paclitaxel Razoxane Tamoxifen Trastuzumab

MeSH Conditions

Breast Neoplasms Cardiotoxicity Inflammatory Breast Neoplasms

Other Conditions

Cardiac Toxicity Inflammatory Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IV Breast Cancer

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID